RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts.
Saved in:
| Title: | RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts. |
|---|---|
| Authors: | Watts GF; School of Medicine, University of Western Australia, Perth, Western Australia, Australia. gerald.watts@uwa.edu.au., Schwabe C; Auckland Clinical Studies, Auckland, New Zealand., Scott R; New Zealand Clinical Research Christchurch, Christchurch, New Zealand., Gladding PA; Te Whatu Ora Waitematā, Auckland, New Zealand., Sullivan D; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Baker J; Middlemore Hospital, Auckland, New Zealand., Clifton P; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Hamilton J; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA., Given B; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA., Melquist S; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA., Zhou R; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA., Chang T; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA., San Martin J; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA., Gaudet D; Department of Medicine, Université de Montréal and ECOGENE 21 Clinical Research Center, Chicoutimi, Quebec, Canada., Goldberg IJ; NYU School of Medicine, NYU Langone Health, New York City, NY, USA., Knowles JW; Stanford Division of Cardiovascular Medicine and Cardiovascular Institute, School of Medicine, Stanford, CA, USA., Hegele RA; University of Western Ontario, London, Ontario, Canada., Ballantyne CM; Baylor College of Medicine, Houston, TX, USA. |
| Source: | Nature medicine [Nat Med] 2023 Sep; Vol. 29 (9), pp. 2216-2223. Date of Electronic Publication: 2023 Aug 25. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37626170 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Watts+GF%22">Watts GF</searchLink>; School of Medicine, University of Western Australia, Perth, Western Australia, Australia. gerald.watts@uwa.edu.au.<br /><searchLink fieldCode="AU" term="%22Schwabe+C%22">Schwabe C</searchLink>; Auckland Clinical Studies, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Scott+R%22">Scott R</searchLink>; New Zealand Clinical Research Christchurch, Christchurch, New Zealand.<br /><searchLink fieldCode="AU" term="%22Gladding+PA%22">Gladding PA</searchLink>; Te Whatu Ora Waitematā, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Sullivan+D%22">Sullivan D</searchLink>; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Baker+J%22">Baker J</searchLink>; Middlemore Hospital, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Clifton+P%22">Clifton P</searchLink>; Royal Adelaide Hospital, Adelaide, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Hamilton+J%22">Hamilton J</searchLink>; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Given+B%22">Given B</searchLink>; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Melquist+S%22">Melquist S</searchLink>; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+R%22">Zhou R</searchLink>; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chang+T%22">Chang T</searchLink>; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22San+Martin+J%22">San Martin J</searchLink>; Arrowhead Pharmaceuticals, Inc., Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gaudet+D%22">Gaudet D</searchLink>; Department of Medicine, Université de Montréal and ECOGENE 21 Clinical Research Center, Chicoutimi, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Goldberg+IJ%22">Goldberg IJ</searchLink>; NYU School of Medicine, NYU Langone Health, New York City, NY, USA.<br /><searchLink fieldCode="AU" term="%22Knowles+JW%22">Knowles JW</searchLink>; Stanford Division of Cardiovascular Medicine and Cardiovascular Institute, School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hegele+RA%22">Hegele RA</searchLink>; University of Western Ontario, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Ballantyne+CM%22">Ballantyne CM</searchLink>; Baylor College of Medicine, Houston, TX, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2023 Sep; Vol. 29 (9), pp. 2216-2223. <i>Date of Electronic Publication: </i>2023 Aug 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37626170 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-023-02494-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2216 Titles: – TitleFull: RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Watts GF – PersonEntity: Name: NameFull: Schwabe C – PersonEntity: Name: NameFull: Scott R – PersonEntity: Name: NameFull: Gladding PA – PersonEntity: Name: NameFull: Sullivan D – PersonEntity: Name: NameFull: Baker J – PersonEntity: Name: NameFull: Clifton P – PersonEntity: Name: NameFull: Hamilton J – PersonEntity: Name: NameFull: Given B – PersonEntity: Name: NameFull: Melquist S – PersonEntity: Name: NameFull: Zhou R – PersonEntity: Name: NameFull: Chang T – PersonEntity: Name: NameFull: San Martin J – PersonEntity: Name: NameFull: Gaudet D – PersonEntity: Name: NameFull: Goldberg IJ – PersonEntity: Name: NameFull: Knowles JW – PersonEntity: Name: NameFull: Hegele RA – PersonEntity: Name: NameFull: Ballantyne CM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2023 Sep Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 29 – Type: issue Value: 9 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |